V0162 a New Long-Acting Bronchodilator for Treatment of Chronic Obstructive Lung Diseases: Preclinical and Clinical Results

Respiratory Research - United Kingdom
doi 10.1186/s12931-015-0227-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Comparative Causal Analysis of the Effects of Long-Acting Muscarinic Antagonist Versus No Long-Acting Bronchodilator Use on Readmission or Mortality After Hospitalization for Chronic Obstructive Pulmonary Disease

Drugs - Real World Outcomes
Pharmacology
2019English

Terminology in Chronic Obstructive Lung Diseases.

Journal of Epidemiology and Community Health
EpidemiologyPublic HealthOccupational HealthEnvironmental
1978English

Effect of Bronchodilator Aerosol on Ventilatory Capacity in Chronic Lung and Heart Diseases

BMJ
1963English

Worldwide Patterns of Bronchodilator Responsiveness: Results From the Burden of Obstructive Lung Disease Study

Thorax
PulmonaryRespiratory Medicine
2012English

Clinical and Immunological Aspects of Chronic Obstructive Lung Disease

Medical Immunology (Russia)
AllergyImmunology
2014English

Global Initiative for Chronic Obstructive Lung Diseases (GOLD): Time to Act

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2001English

Combination Inhaled Steroid and Long-Acting Beta2-Agonist Versus Tiotropium for Chronic Obstructive Pulmonary Disease

2010English

Chronic Obstructive Pulmonary Disease and Bronchodilator Response: Does It Matter?

Barcelona Respiratory Network
2018English

Domiciliary Nebulised Bronchodilator Therapy in Chronic Obstructive Pulmonary Disease

Primary Care Respiratory Journal
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy